First Time Loading...

Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 7.56 USD 2.86% Market Closed
Updated: Apr 30, 2024

Avid Bioservices Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Avid Bioservices Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Avid Bioservices Inc
NASDAQ:CDMO
Revenue
$140.9m
CAGR 3-Years
25%
CAGR 5-Years
31%
CAGR 10-Years
20%
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

Avid Bioservices Inc
Revenue Breakdown

Breakdown by Geography
Avid Bioservices Inc

Not Available

Breakdown by Segments
Avid Bioservices Inc

Total Revenue: 149.3m USD
100%
Manufacturing Revenue: 125.4m USD
84%
Process Development Revenue: 23.9m USD
16%

See Also

What is Avid Bioservices Inc's Revenue?
Revenue
140.9m USD

Based on the financial report for Oct 31, 2023, Avid Bioservices Inc's Revenue amounts to 140.9m USD.

What is Avid Bioservices Inc's Revenue growth rate?
Revenue CAGR 10Y
20%

Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Avid Bioservices Inc have been 25% over the past three years , 31% over the past five years , and 20% over the past ten years .